Stepan (SCL) to Release Quarterly Earnings on Monday

Stepan (NYSE:SCLGet Free Report) is projected to issue its Q4 2025 results before the market opens on Monday, February 23rd. Analysts expect the company to announce earnings of $0.35 per share and revenue of $570.60 million for the quarter. Individuals can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Monday, February 23, 2026 at 9:00 AM ET.

Stepan Trading Up 0.1%

Stepan stock opened at $66.60 on Monday. The firm’s 50-day moving average is $52.72 and its 200-day moving average is $49.13. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.84 and a current ratio of 1.30. Stepan has a 1 year low of $41.82 and a 1 year high of $68.00. The company has a market cap of $1.51 billion, a P/E ratio of 33.64 and a beta of 1.05.

Institutional Trading of Stepan

A number of large investors have recently modified their holdings of SCL. Gendell Jeffrey L acquired a new position in Stepan during the 4th quarter valued at about $430,000. First Trust Advisors LP increased its stake in shares of Stepan by 65.2% in the fourth quarter. First Trust Advisors LP now owns 84,806 shares of the basic materials company’s stock valued at $4,016,000 after purchasing an additional 33,456 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of Stepan by 5.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 477,456 shares of the basic materials company’s stock valued at $22,612,000 after buying an additional 23,097 shares during the last quarter. Ieq Capital LLC boosted its position in shares of Stepan by 49.6% during the fourth quarter. Ieq Capital LLC now owns 16,884 shares of the basic materials company’s stock worth $800,000 after buying an additional 5,599 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Stepan by 9.9% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 55,279 shares of the basic materials company’s stock worth $2,618,000 after buying an additional 4,973 shares in the last quarter. Institutional investors and hedge funds own 82.70% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of Stepan in a research note on Monday, December 29th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Reduce”.

Check Out Our Latest Research Report on SCL

About Stepan

(Get Free Report)

Stepan Company is a global manufacturer of specialty and intermediate chemicals, primarily known for its development and production of surfactants and related specialty products. The company’s portfolio includes a wide range of ingredients used to enhance the performance of consumer and industrial formulations, such as emulsifiers, foam control agents, odor control agents, antimicrobial products and performance additives. These products are integral components in cleaning solutions, personal care items, agrochemical formulations, coatings, oilfield treatments and polymer systems.

Serving a diverse set of end-markets, Stepan’s offerings address both consumer-facing and industrial applications.

Read More

Earnings History for Stepan (NYSE:SCL)

Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.